FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that for the second consecutive year a study designed and sponsored by the Company has been honored with the prestigious R. Earl Robinson Regeneration Award from the American Academy of Periodontology for the most outstanding scientific publication in the field of regenerative medicine and periodontics. The paper, which described the use of new composite endpoints to assess therapeutic outcomes in periodontal clinical trials, was authored by three BMTI executives and two other scientific collaborators.
